{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T08:24:06Z","timestamp":1777105446240,"version":"3.51.4"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1093\/neuonc\/nou142","type":"journal-article","created":{"date-parts":[[2014,7,25]],"date-time":"2014-07-25T05:27:15Z","timestamp":1406266035000},"page":"1599-1606","source":"Crossref","is-referenced-by-count":75,"title":["Precise ex vivo histological validation of heightened cellularity and diffusion-restricted necrosis in regions of dark apparent diffusion coefficient in 7 cases of high-grade glioma"],"prefix":"10.1093","volume":"16","author":[{"given":"Peter S.","family":"LaViolette","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolai J.","family":"Mickevicius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth J.","family":"Cochran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott D.","family":"Rand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Connelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph A.","family":"Bovi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark G.","family":"Malkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wade M.","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen M.","family":"Schmainda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,7,24]]},"reference":[{"key":"key\n\t\t\t\t20170511102257_NOU142C1","volume-title":"WHO Classification of Tumours: Pathology and Genetics of Tumours of the Nervous System","author":"P. Kleihues WC","year":"2000"},{"issue":"2","key":"key\n\t\t\t\t20170511102257_NOU142C2","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1056\/NEJM200101113440207","article-title":"Brain tumors","volume":"344","author":"DeAngelis","year":"2001","journal-title":"N Engl J Med"},{"issue":"10","key":"key\n\t\t\t\t20170511102257_NOU142C3","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med"},{"issue":"11","key":"key\n\t\t\t\t20170511102257_NOU142C4","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1200\/JCO.2009.26.3541","article-title":"Updated response assessment criteria for high-grade gliomas: Response Assessment in Neuro-Oncology working group","volume":"28","author":"Wen","year":"2010","journal-title":"J Clin Oncol"},{"issue":"3","key":"key\n\t\t\t\t20170511102257_NOU142C5","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3171\/jns.1997.86.3.0525","article-title":"Isolation and characterization of human malignant glioma cells from histologically normal brain","volume":"86","author":"Silbergeld","year":"1997","journal-title":"J Neurosurg"},{"issue":"2","key":"key\n\t\t\t\t20170511102257_NOU142C6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3171\/jns.1983.58.2.0159","article-title":"Computerized tomographic and pathologic studies of the untreated, quiescent, and recurrent glioblastoma multiforme","volume":"58","author":"Burger","year":"1983","journal-title":"J Neurosurg"},{"issue":"1","key":"key\n\t\t\t\t20170511102257_NOU142C7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0360-3016(92)91021-E","article-title":"Supratentorial malignant glioma: patterns of recurrence and implications for external beam local treatment","volume":"24","author":"Gaspar","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"15","key":"key\n\t\t\t\t20170511102257_NOU142C8","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1212\/WNL.0b013e3181bc0184","article-title":"Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma","volume":"73","author":"Iwamoto","year":"2009","journal-title":"Neurology"},{"issue":"1","key":"key\n\t\t\t\t20170511102257_NOU142C9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1158\/0008-5472.CAN-10-2602","article-title":"Glioblastoma recurrence after cediranib therapy in patients: lack of \u201crebound\u201d revascularization as mode of escape","volume":"71","author":"di Tomaso","year":"2011","journal-title":"Cancer Res"},{"issue":"16","key":"key\n\t\t\t\t20170511102257_NOU142C10","doi-asserted-by":"crossref","first-page":"4392","DOI":"10.1158\/1078-0432.CCR-12-1557","article-title":"Acquired resistance to anti-VEGF therapy in glioblastoma is associated with a mesenchymal transition","volume":"19","author":"Piao","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"1","key":"key\n\t\t\t\t20170511102257_NOU142C11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/(SICI)1522-2586(199901)9:1<53::AID-JMRI7>3.0.CO;2-2","article-title":"Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas","volume":"9","author":"Sugahara","year":"1999","journal-title":"J Magn Reson Imaging"},{"issue":"6","key":"key\n\t\t\t\t20170511102257_NOU142C12","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/1522-2594(200006)43:6<828::AID-MRM8>3.0.CO;2-P","article-title":"Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging","volume":"43","author":"Lyng","year":"2000","journal-title":"Magn Reson Med"},{"issue":"24","key":"key\n\t\t\t\t20170511102257_NOU142C13","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1093\/jnci\/92.24.2029","article-title":"Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors","volume":"92","author":"Chenevert","year":"2000","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"key\n\t\t\t\t20170511102257_NOU142C14","first-page":"1419","article-title":"Diffusion-weighted imaging of metastatic brain tumors: comparison with histologic type and tumor cellularity","volume":"27","author":"Hayashida","year":"2006","journal-title":"AJNR Am J Neuroradiol"},{"issue":"2","key":"key\n\t\t\t\t20170511102257_NOU142C15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s11547-008-0246-9","article-title":"Malignant renal neoplasms: correlation between ADC values and cellularity in diffusion weighted magnetic resonance imaging at 3T","volume":"113","author":"Manenti","year":"2008","journal-title":"Radiol Med"},{"issue":"2","key":"key\n\t\t\t\t20170511102257_NOU142C16","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2214\/ajr.177.2.1770449","article-title":"Evaluating pediatric brain tumor cellularity with diffusion-tensor imaging","volume":"177","author":"Gauvain","year":"2001","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"key\n\t\t\t\t20170511102257_NOU142C17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neuroimage.2008.06.041","article-title":"Fractional anisotropy and tumor cell density of the tumor core show positive correlation in diffusion tensor magnetic resonance imaging of malignant brain tumors","volume":"43","author":"Kinoshita","year":"2008","journal-title":"Neuroimage"},{"issue":"6","key":"key\n\t\t\t\t20170511102257_NOU142C18","first-page":"1081","article-title":"The role of diffusion-weighted imaging in patients with brain tumors","volume":"22","author":"Kono","year":"2001","journal-title":"AJNR Am J Neuroradiol"},{"issue":"3","key":"key\n\t\t\t\t20170511102257_NOU142C19","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/jmri.22068","article-title":"Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity","volume":"31","author":"Ellingson","year":"2010","journal-title":"J Magn Reson Imaging"},{"issue":"9","key":"key\n\t\t\t\t20170511102257_NOU142C20","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.3174\/ajnr.A0674","article-title":"A prospective study on the added value of pulsed arterial spin-labeling and apparent diffusion coefficients in the grading of gliomas","volume":"28","author":"Kim","year":"2007","journal-title":"AJNR Am J Neuroradiol"},{"issue":"3","key":"key\n\t\t\t\t20170511102257_NOU142C21","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1148\/radiol.2413051276","article-title":"Malignant astrocytic tumors: clinical importance of apparent diffusion coefficient in prediction of grade and prognosis","volume":"241","author":"Higano","year":"2006","journal-title":"Radiology"},{"issue":"944","key":"key\n\t\t\t\t20170511102257_NOU142C22","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1259\/bjr\/25349497","article-title":"Usefulness of diffusion\/perfusion-weighted MRI in patients with non-enhancing supratentorial brain gliomas: a valuable tool to predict tumour grading?","volume":"79","author":"Fan","year":"2006","journal-title":"Br J Radiol"},{"issue":"1","key":"key\n\t\t\t\t20170511102257_NOU142C23","first-page":"60","article-title":"Apparent diffusion coefficients in the evaluation of high-grade cerebral gliomas","volume":"22","author":"Castillo","year":"2001","journal-title":"AJNR Am J Neuroradiol"},{"issue":"3","key":"key\n\t\t\t\t20170511102257_NOU142C24","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1053\/crad.2001.0741","article-title":"Diffusion MR imaging in glioma: does it have any role in the pre-operation determination of grading of glioma?","volume":"57","author":"Lam","year":"2002","journal-title":"Clin Radiol"},{"issue":"6","key":"key\n\t\t\t\t20170511102257_NOU142C25","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1200\/JCO.2009.25.0233","article-title":"Diffusion magnetic resonance imaging detects pathologically confirmed, nonenhancing tumor progression in a patient with recurrent glioblastoma receiving bevacizumab","volume":"28","author":"Gerstner","year":"2009","journal-title":"J Clin Oncol"},{"issue":"9","key":"key\n\t\t\t\t20170511102257_NOU142C26","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.3174\/ajnr.A3053","article-title":"Persistent diffusion-restricted lesions in bevacizumab-treated malignant gliomas are associated with improved survival compared with matched controls","volume":"33","author":"Mong","year":"2012","journal-title":"AJNR Am J Neuroradiol"},{"issue":"27","key":"key\n\t\t\t\t20170511102257_NOU142C27","doi-asserted-by":"crossref","first-page":"e477","DOI":"10.1200\/JCO.2010.29.2029","article-title":"Bevacizumab-induced diffusion restriction in patients with glioma: tumor progression or surrogate marker of hypoxia?","volume":"28","author":"Rieger","year":"2010","journal-title":"J Clin Oncol"},{"issue":"1","key":"key\n\t\t\t\t20170511102257_NOU142C28","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11060-009-0098-8","article-title":"Bevacizumab-induced diffusion-restricted lesions in malignant glioma patients","volume":"99","author":"Rieger","year":"2010","journal-title":"J Neurooncol"},{"issue":"7","key":"key\n\t\t\t\t20170511102257_NOU142C29","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.3174\/ajnr.A2479","article-title":"Isolated diffusion restriction precedes the development of enhancing tumor in a subset of patients with glioblastoma","volume":"32","author":"Gupta","year":"2011","journal-title":"AJNR Am J Neuroradiol"},{"key":"key\n\t\t\t\t20170511102257_NOU142C30","article-title":"Reduced diffusion and perfusion in bevacizumab-induced diffusion restricted necrosis versus brain tumor hypercellularity","author":"LaViolette","year":"2013","journal-title":"Proc ISMRM Salt Lake City"},{"key":"key\n\t\t\t\t20170511102257_NOU142C31","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3389\/fonc.2013.00258","article-title":"Restriction-spectrum imaging of bevacizumab-related necrosis in a patient with GBM","volume":"3","author":"Farid","year":"2013","journal-title":"Front Oncol"},{"issue":"7","key":"key\n\t\t\t\t20170511102257_NOU142C32","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1200\/JCO.2010.31.4815","article-title":"Exacerbation of cerebral radiation necrosis by bevacizumab","volume":"29","author":"Jeyaretna","year":"2011","journal-title":"J Clin Oncol"}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/16\/12\/1599\/16861927\/nou142.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T10:45:25Z","timestamp":1503571525000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-lookup\/doi\/10.1093\/neuonc\/nou142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,24]]},"references-count":32,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2014,7,24]]},"published-print":{"date-parts":[[2014,12]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/nou142","relation":{},"ISSN":["1523-5866","1522-8517"],"issn-type":[{"value":"1523-5866","type":"electronic"},{"value":"1522-8517","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7,24]]}}}